A phase I study of CPT-11 plus chronomodulated (chrono) 5-Fluorouracil (5-FU) and L-folinic acid (FA) in advanced colorectal cancer (ACC) patients

被引：0
|
作者：
Garufi, C
Tampellini, M
D'Attino, RM
Nistico, C
Aschelter, AM
Pugliese, P
Caterino, M
Giunta, S
Faranda, A
Tropea, F
Comis, S
Dogliotti, L
Terzoli, E
机构：
[1] Ist Regina Elena, I-00161 Rome, Italy
[2] Univ Turin, Turin, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178P
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [31] Phase III study of bolus 5-fluorouracil (5-FU)/folinic acid vs high dose 24h 5-FU infusion/folinic acid (FA) plus oxaliplatin(OXA) in metastatic colorectal cancer (MCRC).
    Hospers, G
    Schaapveld, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 254S - 254S
  • [32] CHEMOTHERAPY OF ADVANCED COLORECTAL-CARCINOMA WITH FOLINIC ACID 5-FLUOROURACIL (FA FU)
    SCHALHORN, A
    LERNER, J
    POSSINGER, K
    WILMANNS, W
    BLUT, 1988, 57 (04): : 245 - 245
  • [33] Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma - A phase III randomized study
    Tsavaris, Nicolas
    Kosmas, Christos
    Skopelitis, Helias
    Papadoniou, Nicitas
    Polyzos, Aristidis
    Zografos, George
    Adoniou, Efstathios
    Gryniatsos, John
    Felekouras, Evangelos
    Zacharakis, Michalis
    Sigala, Francheska
    Bacoyiannis, Christos
    Papastratis, George
    Papalambros, Efstathios
    CHEMOTHERAPY, 2007, 53 (04) : 282 - 291
  • [34] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [35] 5-fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group
    Maiello, E
    Gebbia, V
    Giuliani, F
    Paoletti, G
    Gebbia, N
    Cigolari, S
    Fortunato, S
    Pedicini, T
    Borsellino, N
    Lopez, M
    Colucci, G
    ANNALS OF ONCOLOGY, 2000, 11 (08) : 1045 - 1051
  • [36] A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer
    Yamaguchi, Y
    Minami, K
    Kawabuchi, Y
    Emi, M
    HEPATO-GASTROENTEROLOGY, 2006, 53 (68) : 201 - 205
  • [37] A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma
    Kalofonos, HP
    Skarlos, D
    Bafaloukos, D
    Papakostas, P
    Bamias, A
    Janinis, J
    Timotheadou, E
    Kouvatseas, G
    Stavropoulos, M
    Economopulos, T
    Fountzilas, G
    CANCER INVESTIGATION, 2003, 21 (06) : 855 - 862
  • [38] CPT-11 combined or alternated with 5 fluoruracil folinic acid (5-FU/FA) vs Mayo clinic regimen in first line therapy of advanced colorectal cancer (ACRC)
    Graeven, U
    Ridwelski, K
    Manns, M
    Schoelmerich, J
    Espana, P
    Murias, A
    Carlsson, G
    Borner, M
    Oulid-Aissa, D
    Boussard, B
    Schmiegel, W
    GASTROENTEROLOGY, 2001, 120 (05) : A611 - A611
  • [39] A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases
    Oliver F Bathe
    Scott Ernst
    Francis R Sutherland
    Elijah Dixon
    Charles Butts
    David Bigam
    David Holland
    Geoffrey A Porter
    Jennifer Koppel
    Scot Dowden
    BMC Cancer, 9
  • [40] Phase II study of gemcitabine, cisplatin, folinic acid (FA) and infusional 5-fluorouracil (5-FU) in patients with inoperable esophageal cancer (IEC).
    Hilbig, A
    Stieler, J
    Pelzer, U
    Okenga, J
    Hintze, R
    Roll, L
    Gövercin, M
    Arning, M
    Riess, H
    Oettle, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 372S - 372S
12345